Advertisment: Fluence » Fluence Order 95 » CBT ROS Banner 970x250 - Start June 18 » FLU-DBA_SPYDR3_970 x 250

Oregon to Ban Sale of Synthetic Cannabinoids Starting July 1

Next year, starting in July 2023, the state will allow retailers licensed by the Oregon Liquor and Cannabis Commission to sell synthetic cannabinoids—as long as they are approved by the FDA.

Oregon Capitol Adobe Stock Credit Jpldesigns Resized
jpldesigns | Adobe Stock

In an unprecedented move, Oregon will ban the sale of all synthetic cannabinoids next month in an effort to crack down on unregulated products that have popped up on the shelves of grocery stores and gas stations.

Oregon will prohibit the sale of synthetic cannabinoids, such as delta-8 THC, starting July 1, according to The Oregonian, and next year, starting in July 2023, the state will allow retailers licensed by the Oregon Liquor and Cannabis Commission (OLCC) to sell synthetic cannabinoids—as long as they are approved by the U.S. Food and Drug Administration (FDA).

Regulators claim the restrictions stem from concerns about the chemicals used to produce synthetic cannabinoids, The Oregonian reported.

“We have testing for pesticides,” Steven Crowley, the OLCC’s hemp and processing compliance specialist, told the news outlet. “We have testing for residual solvents from the extraction process. We don’t have any testing for any of the whole universe of chemical reagents that you could use to synthetically turn one cannabinoid into something else, or for any of the byproducts of that reaction.”

As The Oregonian pointed out, the FDA has so far approved only a handful of hemp-derived products, meaning the agency is unlikely to grant the approval necessary to bring synthetic cannabinoids to the shelves of OLCC-licensed retailers next year.

Wyld, an Oregon-based cannabis producer that sells gummies containing a synthetic version of cannabinol (CBN), sells its products at local grocers, which will be illegal after July 1.

“There are ways to regulate it and there are definitely ways that we can ensure that the end product that’s being sold is subject to enough safety testing and safety standards to ensure, to the degree possible, the safety of the product without any sort of larger federal research grants or anything like that,” Gabe Parton Lee, general counsel at Wyld and Wyld CBD, told The Oregonian.

The company is currently circulating a petition against the rule change, according to the news outlet.

Advertisment: Frank Mayer » Frank Mayer Order 84 » CBT ROS Medium Rectangle 300x250 July 2025 » CBT Web Ad - July 2025
Advertisment: Hanwha Vision » Hanwha Vision Order 78 » CBT ROS 300x250 Medium Rectangle July 2025 » D53_Cannabis-Business-Times_300x250_v1
Page 1 of 35
Next Page
Advertisment: Greentank » Greentank Order 111 » CBT ROS Mobile Adhesion 360x120 July 2025 » GT AC ADS 600X200@2x